Why IMU is a multi multi bagger, page-14112

Your question gets me thinking:
"why would any of them just sit back and wait and not lock away a deal even if it's just a strategic move to take it off the table from competitors?"

Thoughts that jump into my head (a little crazy - thinking out loud here);
If our products do what they say they do on the bottle, will we in the long term, take money away from BP?
Yes, we are trialling together with some of BP treatments, but what happens when their products are no longer needed as ours is better?
Their goal is to make as much money as possible. Our products disrupt their goal. Yes, they can buy us out/licence deal etc,
but it makes me think at what point and do they really want our products to work at all? It's my conspiracy part of the brain taking over here...

Funny what can be asked of Chat GPT - The Following is created by Ai:

Title: The Sinister Plot: Big Pharmaceutical's Conspiracy to Sabotage Our Company

Introduction:
In this shocking exposé, we delve into the clandestine operations of Big Pharmaceutical, unraveling a twisted conspiracy to undermine our company and prevent our revolutionary products from reaching the market. As we explore the chilling motivations behind their actions, it becomes clear that their primary objective is to maintain their stranglehold on the healthcare industry and maximize profits, even at the expense of our collective well-being.

1. Undermining Our Success:
Big Pharmaceutical's insidious strategy is to ensure our products never reach their full potential. By keeping our game-changing innovations off the table, they maintain a monopoly over the market, guaranteeing their continued financial dominance. If our products live up to their claims and deliver long-term benefits, they pose a serious threat to Big Pharmaceutical's revenue streams, as patients would no longer require their expensive ongoing treatments.

2. Profits Over People:
The greed-driven nature of Big Pharmaceutical is evident in their relentless pursuit of profit, even if it means perpetuating illness among the population. Our disruptive products have the potential to revolutionize healthcare, offering effective solutions that could significantly improve people's lives. However, this threatens Big Pharmaceutical's bottom line, as their profits heavily rely on the perpetuation of chronic ailments and the continuous demand for their expensive medications.

3. Hoping for Failure:
Rather than embracing our innovations or seeking partnership opportunities, Big Pharmaceutical secretly revels in the prospect of our failure. They understand that the success of our company could lead to a paradigm shift in the healthcare industry, one that challenges their hegemony. By hoping for our downfall, they ensure that alternative solutions remain suppressed, allowing them to maintain their grip on the market and the fortunes derived from it.

Conclusion:
The veil has been lifted, exposing the dark underbelly of Big Pharmaceutical's conspiratorial campaign against our company. Their relentless pursuit of profit and power has driven them to sabotage our success, thwart our groundbreaking innovations, and hinder the advancement of healthcare. As we stand against their treachery, we must remain vigilant, continuing to champion the cause of true health and well-being, untainted by the profit-driven motives of the pharmaceutical giants.